Archives
European Journal of Rheumatology
Volume 7 · Issue 2
ORIGINAL ARTICLE
Effects of biologic drugs on the prognosis of rheumatoid arthritis among patients with poor diabetes control
ORIGINAL ARTICLE
Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry
ORIGINAL ARTICLE
Comparison of clinical features in FMF patients according to severity scores: An analysis with the ISSF scoring system
ORIGINAL ARTICLE
Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore
ORIGINAL ARTICLE
Does the item ‘hands on floor’ add value to the Beighton score in identifying joint hypermobility?
CASE-BASED REVIEW
Two cases of calcium pyrophosphate deposition disease (CPPD) presented with spondylodiscitis
SHORT COMMUNICATION
Conducting research in a pandemic: The power of social media
LETTER TO THE EDITOR
A single-nucleotide polymorphism (rs8176070) of lncRNA PART1 may reflect the risk for knee osteoarthritis
SHORT COMMUNICATION
Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19
IMAGES IN RHEUMATOLOGY
Tuberculosis monoarthritis of the wrist mimicking rheumatoid arthritis
SHORT COMMUNICATION
The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia
IMAGES IN RHEUMATOLOGY
Raccoon eyes in cutaneous neonatal lupus syndrome
SHORT COMMUNICATION
Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China
IMAGES IN RHEUMATOLOGY
Lupus with “thumb-prints,” “targets,” and “combs”
IMAGES IN RHEUMATOLOGY
Hypercholesterolemic arthritis in a young female
SHORT COMMUNICATION
Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation
ERRATUM
Erratum
SHORT COMMUNICATION
Coronavirus 2019 outbreak pathogenesis: Why China and Italy?
SHORT COMMUNICATION
A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics
SHORT COMMUNICATION
Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists
SHORT COMMUNICATION
Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence
SHORT COMMUNICATION
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus
SHORT COMMUNICATION
Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic
SHORT COMMUNICATION